Table 3.
Disposition of the Singaporean cohort according to NOGG guidance
| Category | Number | % | Mean BMD T-score | Mean 10-year probability without BMD (FRAX) (%) | Mean 10-year probability with BMD (FRAX) (%) | ||
|---|---|---|---|---|---|---|---|
| MOF | Hip | MOF | Hip | ||||
| Entire cohort | 29,323 | 100 | −1.89 | 7.5 | 2.8 | 8.0 | 3.0 |
| Treated (prior fragility fracture) | 1927 | 6.6 | −2.18 | 15.2 | 6.5 | 15.1 | 6.3 |
| Otherwise eligible for treatment* | 3019 | 10.3 | −2.94 | 9.8 | 4.3 | 15.3 | 8.5 |
| BMD tests | 17,721 | 60.4 | −1.98 | 7.7 | 2.9 | 8.2 | 3.2 |
| No treatment | 24,377 | 83.1 | −1.74 | 6.6 | 2.3 | 6.5 | 2.0 |
*No prior fragility fracture but high FRAX score